Literature DB >> 18476580

[Virological surveillance on hemorrhagic fever with renal syndrome in Hunan province in 2006].

De-Fang Dai1, Hong Zhang, Yun-Zhi Liu, Yi-Wei Huang, Li-Dong Gao, Fu-Qiang Liu, Ge Zeng.   

Abstract

OBJECTIVE: To understand the rate of viral carrying status among rodents as well as genotypes and distribution of Hantaviruses (HV) isolated in Hunan province.
METHODS: With DFA, the HV antigen in lung tissues of rodents was detected. The total viral RNA was extracted from the lung tissues of the HV infected rats and amplified with reverse transcrition-polymerase chain reaction (RT-PCR), using the HV genotype specific primers. The amplified genes were then sequenced and subjected to genotyping and homologic analysis.
RESULTS: The average density of rodents was 3.15% and the virus carrying rate among rodents was 1.31%. Data from genotype analysis showed that the HV isolated from seven lung specimens taken from Rattus norvgicus, Apodemus agraius, Mus musculus, Rattus flavipectus among indoor rodents in Shaodong and Liuyang belonged to HV type II (SEOV), and one isolated from Apodemus agraius in Shaungfen belonged to HV type I (HTNV) among outdoor rodents. Six strains were sequenced successfully and the homology between six srains was 88.3%-100%. The homology of HN1, HN2, HN4, HN6 came from Liuyang and the HN7 and HN8 from Shaodong were both 100% while the homology between L99 and the strains from Liuyang and Shaodong were 94.4% and 88.3% respectively.
CONCLUSION: HV type II (SEOV) and the HV type I (HTNV) were all existed in Hunan province while SEOV was the main genotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18476580

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  1 in total

1.  Prevalence of hemorrhagic fever with renal syndrome in Qingdao City, China, 2010-2014.

Authors:  Fachun Jiang; Zhentang Zhang; Liyan Dong; Bi Hao; Zaifeng Xue; Dongqiang Ma; Hang Su; Hong-Ling Wen; Hao Yu; Xue-Jie Yu
Journal:  Sci Rep       Date:  2016-10-27       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.